To evaluate the relationship between baseline serum levels of sortilin, MACE and MALE occurrence after revascularization of T2DM patients with PAD and chronic limb-threatening ischemia (CLTI). The gene discussed is SORT1; the disease is type 2 diabetes mellitus.